ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
7.12
-0.14 (-1.93%)
Apr 29, 2025, 4:00 PM EDT - Market closed
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 69 employees as of December 31, 2024. The number of employees increased by 8 or 13.11% compared to the previous year.
Employees
69
Change (1Y)
8
Growth (1Y)
13.11%
Revenue / Employee
$161,928
Profits / Employee
-$2,644,406
Market Cap
451.77M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ABVX News
- 12 hours ago - Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis - GlobeNewsWire
- 7 days ago - Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones - GlobeNewsWire
- 7 days ago - Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors - GlobeNewsWire
- 4 weeks ago - Abivax publishes financial reports with the French and U.S. securities regulatory agencies - GlobeNewsWire
- 5 weeks ago - Abivax Announces Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025 - GlobeNewsWire
- 3 months ago - Abivax Publishes 2025 Financial Calendar - GlobeNewsWire
- 3 months ago - Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn's and Colitis Organization 20th Annual Congress - GlobeNewsWire